BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:27 PM
 | 
May 17, 2007
 |  BC Extra  |  Company News

FDA panel backs Acambis vaccine

FDA's Vaccines and Related Biological Products Advisory Committee voted 11-0 in favor of both the safety and efficacy of ACAM2000 smallpox vaccine from Acambis (LSE:ACM) for use in subjects at high risk of exposure. The committee also voted to recommend a risk...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >